60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (or pre-funded warrants) with series A and series B warrants Announced: about US$1M · US$1.74 a share · Warrants at US$1.49 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 30, 2026 |
| Public offering of shares of common stock (or pre-funded warrants) with Series A-1 and Series A-2 warrants Closed: US$5M raised · US$1.9 a share · Warrants at US$1.9 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 16, 2025 |
| Registered direct offering of shares of common stock with concurrent private placement of short-term warrants Announced: US$1.07M · US$0.715 a share · Warrants at US$0.59 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and other general corporate purposes | Feb 5, 2025 |
| Registered direct offering of shares of common stock with concurrent private placement of short-term warrants Announced: US$1.04M · US$1.021 a share · Warrants at US$0.771 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and other general corporate purposes | Jan 29, 2025 |